Immuneed is a specialized service provider supporting drug developers with human-relevant immunological assessments for preclinical-stage molecules. With access to fresh human blood from local donors, Immuneed’s expert team performs comprehensive studies, analyzing how a drug impacts the adaptive and innate immune response—including immune cells, the complement system, cytokines, platelets, and immunoglobulins—and interprets the results. This approach provides drug developers with precise, human-relevant data to support safer, more effective drug development throughout the preclinical phase